{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:12:35Z","timestamp":1793373155374,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Project","award":["2019YFA0100400"],"award-info":[{"award-number":["2019YFA0100400"]}]},{"name":"National Foundation of Sciences and Technology","award":["31971051"],"award-info":[{"award-number":["31971051"]}]},{"name":"National Foundation of Sciences and Technology","award":["31771562"],"award-info":[{"award-number":["31771562"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-alcoholic fatty liver disease (NAFLD) has become a global epidemic disease. Its incidence is associated with type 2 diabetes mellitus (T2DM). Presently, there is no approved pharmacological agents specially developed for NAFLD. One promising disease-modifying strategy is the transplantation of stem cells to promote metabolic regulation and repair of injury.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>In this study, a T2DM model was established through 28-week high-fat diet (HFD) feeding resulting in T2DM-associated NAFLD, followed by the injection of bone marrow mesenchymal stem cells (BMSCs). The morphology, function, and transfer of hepatocyte mitochondria were evaluated in both vivo and in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BMSC implantation resulted in the considerable recovery of increasing weight, HFD-induced steatosis, liver function, and disordered glucose and lipid metabolism. The treatment with BMSC transplantation was accompanied by reduced fat accumulation. Moreover, mitochondrial transfer was observed in both vivo and vitro studies. And the mitochondria-recipient steatotic cells exhibited significantly enhanced OXPHOS activity, ATP production, and mitochondrial membrane potential, and reduced reactive oxygen species levels, which were not achieved by the blocking of mitochondrial transfer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Mitochondrial transfer from BMSCs is a feasible process to combat NAFLD via rescuing dysfunction mitochondria, and has a promising therapeutic effect on metabolism-related diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-021-02663-5","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T09:02:51Z","timestamp":1639213371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice"],"prefix":"10.1186","volume":"12","author":[{"given":"Youkun","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chentao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8626-3490","authenticated-orcid":false,"given":"Guangju","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"issue":"21","key":"2663_CR1","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063\u201372. https:\/\/doi.org\/10.1056\/NEJMra1503519.","journal-title":"N Engl J Med"},{"key":"2663_CR2","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","volume":"50","author":"K Pafili","year":"2021","unstructured":"Pafili K, Roden M. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab. 2021;50:101122. https:\/\/doi.org\/10.1016\/j.molmet.2020.101122.","journal-title":"Mol Metab"},{"issue":"5","key":"2663_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.cmet.2019.10.010","volume":"30","author":"T Kisseleva","year":"2019","unstructured":"Kisseleva T, Brenner DA. The crosstalk between hepatocytes, hepatic macrophages, and hepatic stellate cells facilitates alcoholic liver disease. Cell Metab. 2019;30(5):850\u20132. https:\/\/doi.org\/10.1016\/j.cmet.2019.10.010.","journal-title":"Cell Metab"},{"issue":"9","key":"2663_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13(9):509\u201320. https:\/\/doi.org\/10.1038\/nrendo.2017.56.","journal-title":"Nat Rev Endocrinol"},{"key":"2663_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","author":"S Kumar","year":"2021","unstructured":"Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021. https:\/\/doi.org\/10.1016\/j.addr.2021.113869.","journal-title":"Adv Drug Deliv Rev"},{"key":"2663_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00448-y","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus-mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1038\/s41575-021-00448-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2663_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, Qiu Y, Burns L, Afendy A, Nader F. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021.","journal-title":"J Hepatol"},{"issue":"18","key":"2663_CR8","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2663_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","volume":"71","author":"R Parker","year":"2019","unstructured":"Parker R, Aithal GP, Becker U, Gleeson D, Masson S, Wyatt JI, Rowe IA. Natural history of histologically proven alcohol-related liver disease: a systematic review. J Hepatol. 2019;71(3):586\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2019.05.020.","journal-title":"J Hepatol"},{"issue":"1","key":"2663_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32\u201342. https:\/\/doi.org\/10.1038\/nrgastro.2016.147.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"2663_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20(7):745\u201354. https:\/\/doi.org\/10.1038\/s41556-018-0124-1.","journal-title":"Nat Cell Biol"},{"key":"2663_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ceca.2017.07.005","volume":"69","author":"IE Krabbendam","year":"2018","unstructured":"Krabbendam IE, Honrath B, Culmsee C, Dolga AM. Mitochondrial Ca(2+)-activated K(+) channels and their role in cell life and death pathways. Cell Calcium. 2018;69:101\u201311. https:\/\/doi.org\/10.1016\/j.ceca.2017.07.005.","journal-title":"Cell Calcium"},{"key":"2663_CR13","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37:101674. https:\/\/doi.org\/10.1016\/j.redox.2020.101674.","journal-title":"Redox Biol"},{"issue":"5","key":"2663_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jhep.2020.11.030","volume":"74","author":"Y Kupriyanova","year":"2021","unstructured":"Kupriyanova Y, Zaharia OP, Bobrov P, Karusheva Y, Burkart V, Szendroedi J, Hwang JH, Roden M. Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus. J Hepatol. 2021;74(5):1028\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.030.","journal-title":"J Hepatol"},{"key":"2663_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.redox.2014.11.006","volume":"4","author":"H-M Ni","year":"2015","unstructured":"Ni H-M, Williams JA, Ding W-XJRb,. Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 2015;4:6\u201313.","journal-title":"Redox Biol"},{"issue":"7","key":"2663_CR16","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.18632\/aging.102972","volume":"12","author":"R Li","year":"2020","unstructured":"Li R, Toan S, Zhou H. Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease. Aging. 2020;12(7):6467\u201385. https:\/\/doi.org\/10.18632\/aging.102972.","journal-title":"Aging"},{"issue":"1","key":"2663_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway. Stem Cell Res Ther. 2019;10(1):98. https:\/\/doi.org\/10.1186\/s13287-019-1204-2.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2663_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00441-019-03081-z","volume":"379","author":"X Rong","year":"2020","unstructured":"Rong X, Yang Y, Zhang G, Zhang H, Li C, Wang Y. Antler stem cells as a novel stem cell source for reducing liver fibrosis. Cell Tissue Res. 2020;379(1):195\u2013206. https:\/\/doi.org\/10.1007\/s00441-019-03081-z.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"2663_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13287-020-01891-5","volume":"11","author":"X Yao","year":"2020","unstructured":"Yao X, Wang J, Zhu J, Rong X. The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis. Stem Cell Res Ther. 2020;11(1):379. https:\/\/doi.org\/10.1186\/s13287-020-01891-5.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2663_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13287-021-02441-3","volume":"12","author":"J Gao","year":"2021","unstructured":"Gao J, Yuan J, Liu Q, Wang Y, Wang H, Chen Y, Ding W, Ji G, Lu Z. Adipose-derived stem cells therapy effectively attenuates PM(2.5)-induced lung injury. Stem Cell Res Ther. 2021;12(1):355. https:\/\/doi.org\/10.1186\/s13287-021-02441-3.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"2663_CR21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.addr.2010.08.010","volume":"62","author":"CD Porada","year":"2010","unstructured":"Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev. 2010;62(12):1156\u201366. https:\/\/doi.org\/10.1016\/j.addr.2010.08.010.","journal-title":"Adv Drug Deliv Rev"},{"key":"2663_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger MF, Discher DE, P\u00e9ault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22. https:\/\/doi.org\/10.1038\/s41536-019-0083-6.","journal-title":"NPJ Regen Med"},{"issue":"2","key":"2663_CR23","doi-asserted-by":"publisher","first-page":"e48052","DOI":"10.15252\/embr.201948052","volume":"21","author":"AC Court","year":"2020","unstructured":"Court AC, Le-Gatt A, Luz-Crawford P, Parra E, Aliaga-Tobar V, B\u00e1tiz LF, Contreras RA, Ort\u00fazar MI, Kurte M, Elizondo-Vega R, Maracaja-Coutinho V, Pino-Lagos K, Figueroa FE, Khoury M. Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response. EMBO Rep. 2020;21(2):e48052. https:\/\/doi.org\/10.15252\/embr.201948052.","journal-title":"EMBO Rep"},{"issue":"11","key":"2663_CR24","doi-asserted-by":"publisher","first-page":"e2467","DOI":"10.1038\/cddis.2016.358","volume":"7","author":"D Jiang","year":"2016","unstructured":"Jiang D, Gao F, Zhang Y, Wong DS, Li Q, Tse HF, Xu G, Yu Z, Lian Q. Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage. Cell Death Dis. 2016;7(11):e2467. https:\/\/doi.org\/10.1038\/cddis.2016.358.","journal-title":"Cell Death Dis"},{"key":"2663_CR25","doi-asserted-by":"publisher","unstructured":"Li C, Cheung MKH, Han S, Zhang Z, Chen L, Chen J, Zeng H, Qiu J. Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. 2019. Biosci Rep. https:\/\/doi.org\/10.1042\/bsr20182417.","DOI":"10.1042\/bsr20182417"},{"key":"2663_CR26","doi-asserted-by":"publisher","first-page":"603292","DOI":"10.3389\/fcell.2020.603292","volume":"8","author":"A Mohammadalipour","year":"2020","unstructured":"Mohammadalipour A, Dumbali SP, Wenzel PL. Mitochondrial transfer and regulators of mesenchymal stromal cell function and therapeutic efficacy. Front Cell Dev Biol. 2020;8:603292. https:\/\/doi.org\/10.3389\/fcell.2020.603292.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2663_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12929-018-0429-1","volume":"25","author":"S Paliwal","year":"2018","unstructured":"Paliwal S, Chaudhuri R, Agrawal A, Mohanty S. Regenerative abilities of mesenchymal stem cells through mitochondrial transfer. J Biomed Sci. 2018;25(1):31. https:\/\/doi.org\/10.1186\/s12929-018-0429-1.","journal-title":"J Biomed Sci"},{"issue":"5","key":"2663_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1073\/pnas.0510511103","volume":"103","author":"JL Spees","year":"2006","unstructured":"Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A. 2006;103(5):1283\u20138. https:\/\/doi.org\/10.1073\/pnas.0510511103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2663_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41392-020-00440-z","volume":"6","author":"D Liu","year":"2021","unstructured":"Liu D, Gao Y, Liu J, Huang Y, Yin J, Feng Y, Shi L, Meloni BP, Zhang C, Zheng M, Gao J. Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther. 2021;6(1):65. https:\/\/doi.org\/10.1038\/s41392-020-00440-z.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2663_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/ilar\/ily011","volume":"59","author":"JR Swearengen","year":"2018","unstructured":"Swearengen JR. Common challenges in safety: a review and analysis of AAALAC findings. ILAR J. 2018;59(2):127\u201333. https:\/\/doi.org\/10.1093\/ilar\/ily011.","journal-title":"ILAR J"},{"issue":"10","key":"2663_CR31","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/nprot.2007.304","volume":"2","author":"L Graham","year":"2007","unstructured":"Graham L, Orenstein JM. Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research. Nat Protoc. 2007;2(10):2439\u201350. https:\/\/doi.org\/10.1038\/nprot.2007.304.","journal-title":"Nat Protoc"},{"key":"2663_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-3661-8_10","volume":"1438","author":"H Baribault","year":"2016","unstructured":"Baribault H. Mouse models of type 2 diabetes mellitus in drug discovery. Methods Mol Biol (Clifton, NJ). 2016;1438:153\u201375. https:\/\/doi.org\/10.1007\/978-1-4939-3661-8_10.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"11","key":"2663_CR33","doi-asserted-by":"publisher","first-page":"9602","DOI":"10.1002\/jcb.27068","volume":"119","author":"D Chen","year":"2018","unstructured":"Chen D, Li X, Zhang L, Zhu M, Gao L. A high-fat diet impairs mitochondrial biogenesis, mitochondrial dynamics, and the respiratory chain complex in rat myocardial tissues. J Cell Biochem. 2018;119(11):9602. https:\/\/doi.org\/10.1002\/jcb.27068.","journal-title":"J Cell Biochem"},{"issue":"19","key":"2663_CR34","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1101\/gad.269894.115","volume":"29","author":"GW Dorn 2nd","year":"2015","unstructured":"Dorn GW 2nd, Vega RB, Kelly DP. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev. 2015;29(19):1981\u201391. https:\/\/doi.org\/10.1101\/gad.269894.115.","journal-title":"Genes Dev"},{"key":"2663_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014. https:\/\/doi.org\/10.1155\/2014\/360438.","journal-title":"Oxid Med Cell Longev"},{"key":"2663_CR36","doi-asserted-by":"publisher","first-page":"109083","DOI":"10.1016\/j.biopha.2019.109083","volume":"117","author":"XX Yang","year":"2019","unstructured":"Yang XX, Wang X, Shi TT, Dong JC, Li FJ, Zeng LX, Yang M, Gu W, Li JP, Yu J. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: the alleviating effect and its mechanism of Polygonatum kingianum. Biomed Pharmacother. 2019;117:109083. https:\/\/doi.org\/10.1016\/j.biopha.2019.109083.","journal-title":"Biomed Pharmacother"},{"issue":"31","key":"2663_CR37","doi-asserted-by":"publisher","first-page":"12526","DOI":"10.1073\/pnas.1302455110","volume":"110","author":"C Betz","year":"2013","unstructured":"Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN. Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci U S A. 2013;110(31):12526\u201334. https:\/\/doi.org\/10.1073\/pnas.1302455110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2663_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphys.2017.00460","volume":"8","author":"AKS Camara","year":"2017","unstructured":"Camara AKS, Zhou Y, Wen PC, Tajkhorshid E, Kwok WM. Mitochondrial VDAC1: a key gatekeeper as potential therapeutic target. Front Physiol. 2017;8:460. https:\/\/doi.org\/10.3389\/fphys.2017.00460.","journal-title":"Front Physiol"},{"key":"2663_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.redox.2013.07.004","volume":"2","author":"S Bansal","year":"2014","unstructured":"Bansal S, Biswas G, Avadhani NG. Mitochondria-targeted heme oxygenase-1 induces oxidative stress and mitochondrial dysfunction in macrophages, kidney fibroblasts and in chronic alcohol hepatotoxicity. Redox Biol. 2014;2:273\u201383. https:\/\/doi.org\/10.1016\/j.redox.2013.07.004.","journal-title":"Redox Biol"},{"issue":"11","key":"2663_CR40","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1113\/jp277650","volume":"597","author":"LD Gaspers","year":"2019","unstructured":"Gaspers LD, Pierobon N, Thomas AP. Intercellular calcium waves integrate hormonal control of glucose output in the intact liver. J Physiol. 2019;597(11):2867\u201385. https:\/\/doi.org\/10.1113\/jp277650.","journal-title":"J Physiol"},{"issue":"5","key":"2663_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2012.03.002","volume":"15","author":"L Ozcan","year":"2012","unstructured":"Ozcan L, Wong CC, Li G, Xu T, Pajvani U, Park SK, Wronska A, Chen BX, Marks AR, Fukamizu A, Backs J, Singer HA, Yates JR 3rd, Accili D, Tabas I. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab. 2012;15(5):739\u201351. https:\/\/doi.org\/10.1016\/j.cmet.2012.03.002.","journal-title":"Cell Metab"},{"issue":"5","key":"2663_CR42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","volume":"31","author":"X Wang","year":"2020","unstructured":"Wang X, Cai B, Yang X, Sonubi OO, Zheng Z, Ramakrishnan R, Shi H, Valenti L, Pajvani UB, Sandhu J, Infante RE, Radhakrishnan A, Covey DF, Guan KL, Buck J, Levin LR, Tontonoz P, Schwabe RF, Tabas I. Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis. Cell Metab. 2020;31(5):969-986.e967. https:\/\/doi.org\/10.1016\/j.cmet.2020.03.010.","journal-title":"Cell Metab"},{"issue":"8","key":"2663_CR43","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1007\/s11010-021-04150-0","volume":"476","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhang Y, Jiang Y, Dou X, Li S, Chai H, Qian Q, Wang M. Upregulated SOCC and IP3R calcium channels and subsequent elevated cytoplasmic calcium signaling promote nonalcoholic fatty liver disease by inhibiting autophagy. Mol Cell Biochem. 2021;476(8):3163\u201375. https:\/\/doi.org\/10.1007\/s11010-021-04150-0.","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"2663_CR44","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, K\u00fctting F, Goeser T, Demir M, Steffen HM. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol Off J Ger Card Soc. 2021;110(7):921\u201337. https:\/\/doi.org\/10.1007\/s00392-020-01709-7.","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"issue":"2","key":"2663_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep4.1618","volume":"5","author":"J Vieira Barbosa","year":"2021","unstructured":"Vieira Barbosa J, Lai M. Nonalcoholic fatty liver disease screening in type 2 diabetes mellitus patients in the primary care setting. Hepatol Commun. 2021;5(2):158\u201367. https:\/\/doi.org\/10.1002\/hep4.1618.","journal-title":"Hepatol Commun"},{"issue":"3","key":"2663_CR46","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/dom.14263","volume":"23","author":"Y Komorizono","year":"2021","unstructured":"Komorizono Y, Hosoyamada K, Imamura N, Kajiya S, Hashiguchi Y, Ueyama N, Shinmaki H, Koriyama N, Tsukasa M, Kamada T. Metformin dose increase versus added linagliptin in non-alcoholic fatty liver disease and type 2 diabetes: an analysis of the J-LINK study. Diabetes Obes Metab. 2021;23(3):832\u20137. https:\/\/doi.org\/10.1111\/dom.14263.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"2663_CR47","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jcyt.2017.08.022","volume":"19","author":"M Fathi-Kazerooni","year":"2017","unstructured":"Fathi-Kazerooni M, Tavoosidana G, Taghizadeh-Jahed M, Khanjani S, Golshahi H, Gargett CE, Edalatkhah H, Kazemnejad S. Comparative restoration of acute liver failure by menstrual blood stem cells compared with bone marrow stem cells in mice model. Cytotherapy. 2017;19(12):1474\u201390. https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.022.","journal-title":"Cytotherapy"},{"issue":"11","key":"2663_CR48","first-page":"1640","volume":"56","author":"AC Lyra","year":"2007","unstructured":"Lyra AC, Soares MB, dos Santos RR, Lyra LG. Bone marrow stem cells and liver disease. Gut. 2007;56(11):1640 (author reply 1640\u20131641).","journal-title":"Gut"},{"key":"2663_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-016-0792-1","volume":"14","author":"B Huang","year":"2016","unstructured":"Huang B, Cheng X, Wang H, Huang W, la Ga HuZ, Wang D, Zhang K, Zhang H, Xue Z, Da Y, Zhang N, Hu Y, Yao Z, Qiao L, Gao F, Zhang R. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016;14:45. https:\/\/doi.org\/10.1186\/s12967-016-0792-1.","journal-title":"J Transl Med"},{"issue":"3","key":"2663_CR50","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.3892\/mmr.2017.8326","volume":"17","author":"H Wang","year":"2018","unstructured":"Wang H, Zhang H, Huang B, Miao G, Yan X, Gao G, Luo Y, Chen H, Chen W, Yang L. Mesenchymal stem cells reverse high-fat diet-induced non-alcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice. Mol Med Rep. 2018;17(3):3769\u201374. https:\/\/doi.org\/10.3892\/mmr.2017.8326.","journal-title":"Mol Med Rep"},{"issue":"6","key":"2663_CR51","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1111\/jcmm.16338","volume":"25","author":"L Li","year":"2021","unstructured":"Li L, Zeng X, Liu Z, Chen X, Li L, Luo R, Liu X, Zhang J, Liu J, Lu Y, Cheng J, Chen Y. Mesenchymal stromal cells protect hepatocytes from lipotoxicity through alleviation of endoplasmic reticulum stress by restoring SERCA activity. J Cell Mol Med. 2021;25(6):2976\u201393. https:\/\/doi.org\/10.1111\/jcmm.16338.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2663_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrendo.2011.240","volume":"8","author":"L Koch","year":"2012","unstructured":"Koch L. Metabolism: mitochondrial pathways in NAFLD. Nat Rev Endocrinol. 2012;8(3):129. https:\/\/doi.org\/10.1038\/nrendo.2011.240.","journal-title":"Nat Rev Endocrinol"},{"key":"2663_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2016.00107","volume":"4","author":"D Torralba","year":"2016","unstructured":"Torralba D, Baixauli F, S\u00e1nchez-Madrid F. Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer. Front Cell Dev Biol. 2016;4:107. https:\/\/doi.org\/10.3389\/fcell.2016.00107.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"2663_CR54","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759\u201365. https:\/\/doi.org\/10.1038\/nm.2736.","journal-title":"Nat Med"},{"issue":"9","key":"2663_CR55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/embj.201386030","volume":"33","author":"T Ahmad","year":"2014","unstructured":"Ahmad T, Mukherjee S, Pattnaik B, Kumar M, Singh S, Kumar M, Rehman R, Tiwari BK, Jha KA, Barhanpurkar AP, Wani MR, Roy SS, Mabalirajan U, Ghosh B, Agrawal A. Miro1 regulates intercellular mitochondrial transport and enhances mesenchymal stem cell rescue efficacy. EMBO J. 2014;33(9):994\u20131010. https:\/\/doi.org\/10.1002\/embj.201386030.","journal-title":"EMBO J"},{"issue":"5660","key":"2663_CR56","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.1093133","volume":"303","author":"A Rustom","year":"2004","unstructured":"Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science (New York, NY). 2004;303(5660):1007\u201310. https:\/\/doi.org\/10.1126\/science.1093133.","journal-title":"Science (New York, NY)"},{"issue":"8","key":"2663_CR57","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/stem.2372","volume":"34","author":"MV Jackson","year":"2016","unstructured":"Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A, O\u2019Kane CM, Krasnodembskaya AD. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells. 2016;34(8):2210\u201323. https:\/\/doi.org\/10.1002\/stem.2372.","journal-title":"Stem Cells"},{"issue":"10","key":"2663_CR58","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364. https:\/\/doi.org\/10.1016\/j.cell.2021.04.015.","journal-title":"Cell"},{"issue":"4","key":"2663_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373\u201383. https:\/\/doi.org\/10.1083\/jcb.201211138.","journal-title":"J Cell Biol"},{"issue":"1","key":"2663_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cpmo.21","volume":"7","author":"PM Quiros","year":"2017","unstructured":"Quiros PM, Goyal A, Jha P, Auwerx J. Analysis of mtDNA\/nDNA ratio in mice. Curr Protoc Mouse Biol. 2017;7(1):47\u201354. https:\/\/doi.org\/10.1002\/cpmo.21.","journal-title":"Curr Protoc Mouse Biol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02663-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T21:41:05Z","timestamp":1639258865000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02663-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2663"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02663-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed following the guidelines of laboratory animal care (NIH Publication No. 85-23, revised 1996) and with approval from the Institute of Biophysics Committee for Animal Care (Approval No. SYXK2019062).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"602"}}